Header Logo

EVELINE BARBIERI

Concepts (143)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with EVELINE BARBIERI's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that EVELINE BARBIERI has written about over time.
Tumor Lysis Syndrome, 2 publications between 2005 and 2005, average publication date January 2005. HCT116 Cells, 2 publications between 2006 and 2013, average publication date April 2010. Imidazoles, 3 publications between 2006 and 2013, average publication date August 2010. Piperazines, 3 publications between 2006 and 2013, average publication date August 2010. Proto-Oncogene Proteins c-mdm2, 5 publications between 2006 and 2017, average publication date October 2011. Tumor Suppressor Protein p53, 9 publications between 2006 and 2021, average publication date May 2014. Gene Expression Regulation, Neoplastic, 7 publications between 2009 and 2021, average publication date March 2015. Neuroblastoma, 14 publications between 2006 and 2022, average publication date January 2016. Apoptosis, 5 publications between 2006 and 2021, average publication date March 2016. N-Myc Proto-Oncogene Protein, 6 publications between 2009 and 2022, average publication date August 2016. Xenograft Model Antitumor Assays, 5 publications between 2011 and 2021, average publication date February 2017. Cell Line, Tumor, 10 publications between 2011 and 2022, average publication date August 2017. TOR Serine-Threonine Kinases, 1 publications between 2017 and 2017, average publication date August 2017. Chromatin Assembly Factor-1, 2 publications between 2013 and 2021, average publication date October 2017. Circulating MicroRNA, 1 publications between 2018 and 2018, average publication date December 2018. Aurora Kinase A, 1 publications between 2021 and 2021, average publication date June 2021. Cyclopentanes, 1 publications between 2021 and 2021, average publication date June 2021. Nuclear Receptor Subfamily 1, Group F, Member 1, 1 publications between 2021 and 2021, average publication date June 2021. Fatty Acids, 1 publications between 2022 and 2022, average publication date June 2022. G1 Phase, 1 publications between 2024 and 2024, average publication date January 2024.

To see the data from this visualization as text, click here.
BARBIERI's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (143)
Explore
_
Co-Authors (25)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_